Kevin Toh

Associate

kevin-toh
  • JD, Harvard Law School, 2014
  • BS (Biochemistry), University of Miami, 2009

Qualifications

  • Massachusetts, 2016
  • New York, 2015
  • Chinese (Mandarin)
  • Japanese

Kevin Toh

Associate

Kevin Toh is an associate in the securities and public companies group where he focuses his practice on capital markets and mergers & acquisitions. Kevin graduated with a degree in biochemistry and has experience representing both issuers and investment banks in debt and equity offerings.

Prior to joining Ropes & Gray in 2017, Kevin practiced law at a leading law firm in New York and was a summer associate at a Japanese law firm in Tokyo.

Experience

  • Represented a Cambridge-based pharmaceutical company in its acquisition of drug product candidates for the treatment of amyotrophic lateral sclerosis. 
  • Represented Immucor Inc. in its notes exchange offer
  • Represented the Independent Transactions Committee of the Board of Directors of Akcea Therapeutics in connection with a licensing transaction and related shareholder vote for the acquisition of drug product candidates
  • Represented PQ Group Holdings in its initial public offering
  • Represented Cablevision Corp. in its $17 billion sale to Altice N.V. *
  • Represented Orix Corp. in the IPO of its subsidiary, Houlihan Lokey, Inc.*
  • Represented Castleton Commodities in its purchase of an investment bank’s global oil merchanting business*
  • Represented the dealer manager in a tender offer for outstanding notes issued by Nelnet, Inc.*
  • Represented the underwriters in multiple offerings of notes and preferred stock for various companies, including SunTrust Bank, Associated Banc-Corp. and BOK Financial Corp.*
*Representations completed prior to joining Ropes & Gray.
Cookie Settings